FUT8 and prostate carcinoma: The relative quantitative mRNA analysis from wild types (LNCaP and LAPC4) and the androgen-resistant prostate cancer cells (LNCaP-95 and LAPC4-AI) revealed overexpression of FUT8 in both androgen-resistant prostate cancer cell lines (Fig. 2a).